BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36634151)

  • 1. Structure-Activity Relationship Studies of Venglustat on NTMT1 Inhibition.
    Deng Y; Dong G; Meng Y; Noinaj N; Huang R
    J Med Chem; 2023 Jan; 66(2):1601-1615. PubMed ID: 36634151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venglustat Inhibits Protein N-Terminal Methyltransferase 1 in a Substrate-Competitive Manner.
    Dong G; Deng Y; Yasgar A; Yadav R; Talley D; Zakharov AV; Jain S; Rai G; Noinaj N; Simeonov A; Huang R
    J Med Chem; 2022 Sep; 65(18):12334-12345. PubMed ID: 36074125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Cell-Potent and Selective Peptidomimetic Inhibitors of Protein N-Terminal Methyltransferase 1.
    Dong G; Iyamu ID; Vilseck JZ; Chen D; Huang R
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and kinetic analysis of potent protein N-terminal methyltransferase 1 inhibitors.
    Zhang G; Richardson SL; Mao Y; Huang R
    Org Biomol Chem; 2015 Apr; 13(14):4149-54. PubMed ID: 25712161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Peptidomimetic Inhibitors of NTMT1/2: Rational Design, Synthesis, Characterization, and Crystallographic Studies.
    Mackie BD; Chen D; Dong G; Dong C; Parker H; Schaner Tooley CE; Noinaj N; Min J; Huang R
    J Med Chem; 2020 Sep; 63(17):9512-9522. PubMed ID: 32689795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based Discovery of Cell-Potent Peptidomimetic Inhibitors for Protein N-Terminal Methyltransferase 1.
    Chen D; Dong G; Deng Y; Noinaj N; Huang R
    ACS Med Chem Lett; 2021 Mar; 12(3):485-493. PubMed ID: 33738076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic mechanism of protein N-terminal methyltransferase 1.
    Richardson SL; Mao Y; Zhang G; Hanjra P; Peterson DL; Huang R
    J Biol Chem; 2015 May; 290(18):11601-10. PubMed ID: 25771539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoproteomic Study Uncovers HemK2/KMT9 As a New Target for NTMT1 Bisubstrate Inhibitors.
    Chen D; Meng Y; Yu D; Noinaj N; Cheng X; Huang R
    ACS Chem Biol; 2021 Jul; 16(7):1234-1242. PubMed ID: 34192867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Bisubstrate Inhibitors for Protein N-Terminal Methyltransferase 1.
    Chen D; Dong G; Noinaj N; Huang R
    J Med Chem; 2019 Apr; 62(7):3773-3779. PubMed ID: 30883119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1.
    Zhou Q; Wu W; Jia K; Qi G; Sun XS; Li P
    Eur J Med Chem; 2022 Dec; 244():114830. PubMed ID: 36228414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.
    Chen D; Dong C; Dong G; Srinivasan K; Min J; Noinaj N; Huang R
    J Med Chem; 2020 Aug; 63(15):8419-8431. PubMed ID: 32605369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for substrate recognition by the human N-terminal methyltransferase 1.
    Dong C; Mao Y; Tempel W; Qin S; Li L; Loppnau P; Huang R; Min J
    Genes Dev; 2015 Nov; 29(22):2343-8. PubMed ID: 26543161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific methylation on α-N-terminus of peptides through chemical and enzymatic methods.
    Meng Y; Huang R
    Methods Enzymol; 2023; 684():113-133. PubMed ID: 37230586
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Jia K; Huang G; Wu W; Shrestha R; Wu B; Xiong Y; Li P
    Chem Sci; 2019 Sep; 10(35):8094-8099. PubMed ID: 31857877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three's a crowd - why did three N-terminal methyltransferases evolve for one job?
    Conner MM; Schaner Tooley CE
    J Cell Sci; 2023 Jan; 136(2):. PubMed ID: 36647772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing regulation of the Nα-trimethylase METTL11A by its family members METTL11B and METTL13.
    Parker HV; Schaner Tooley CE
    J Biol Chem; 2023 Apr; 299(4):104588. PubMed ID: 36889590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-guided DOT1L probe optimization by label-free ligand displacement.
    Yi JS; Federation AJ; Qi J; Dhe-Paganon S; Hadler M; Xu X; St Pierre R; Varca AC; Wu L; Marineau JJ; Smith WB; Souza A; Chory EJ; Armstrong SA; Bradner JE
    ACS Chem Biol; 2015 Mar; 10(3):667-74. PubMed ID: 25397901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of selective protein arginine methyltransferase 5 inhibitors and biological evaluations.
    Ji S; Ma S; Wang WJ; Huang SZ; Wang TQ; Xiang R; Hu YG; Chen Q; Li LL; Yang SY
    Chem Biol Drug Des; 2017 Apr; 89(4):585-598. PubMed ID: 27714957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal-Specific Super Enhancer in Neuropathic Pain.
    Tao Y; Wang QH; Li XT; Liu Y; Sun RH; Xu HJ; Zhang M; Li SY; Yang L; Wang HJ; Hao LY; Cao JL; Pan Z
    J Neurosci; 2023 Dec; 43(49):8547-8561. PubMed ID: 37802656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors.
    Hou Z; Min W; Zhang R; Niu A; Li Y; Cao L; Han J; Luo C; Yang P; Ding H
    Bioorg Med Chem Lett; 2020 May; 30(9):127061. PubMed ID: 32173197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.